PRTO News and Press, Proteon Therapeutics Inc. From 03/13/19

Proteon Therapeutics (NASDAQ: PRTO ): Q4 GAAP EPS of -$0.27. More news on: Proteon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced its financial results for the year ended Dec...

Gainers:  Bio-Path Holdings (NASDAQ: BPTH ) +180% . Renren (NYSE: RENN ) +47% . Seelos Therapeutics (NASDAQ: SEEL ) +28% . Abercrombie & Fitch (NYSE: ANF ) +24% . Aytu BioScience (NASDAQ: AYTU ) +24% . OHR Pharmaceutical (NASDAQ: OHRP ) +23% . Proteon Therapeutics (NASDAQ: P...

WALTHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today announced that Company management will present at the Co...

CORAL GABLES, FL / ACCESSWIRE / February 12, 2019 / The healthcare stock market's success is intrinsically connected to victories of companies working in the healthcare industry. Now, more than ever, consumers are insistent that companies take their needs into consideration when designing ...

Avalon GloboCare ( OTCQB:AVCO ) +23%  on announcing breakthrough in identifying human angiogenic exosomes/extracellular vesicles. More news on: Avalon GloboCare Corp., NuVasive, Inc., Camtek Ltd., Stocks on the move, Read more ...

Thinly traded nano cap Proteon Therapeutics ( PRTO -3% ) slips on almost double normal volume, albeit on turnover of only 86K shares. More news on: Proteon Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...

WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc.  (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced the publication in the Journal of Va...